SGMO Financial Facts

Research grants: 256K
Loss from operations: -8.17M
See Full Income Statement

Total assets: -149.57M
Additional paid-in capital: -686.38M
See Full Balance Sheet

Sangamo Biosciences Inc. (SGMO) Earnings

  |   Expand Research on SGMO
Next EPS Date 5/9/14 *Est. EPS Growth Rate -85.7% *Last Qtr.
Average EPS % Beat Rate +20.9% Revenue Growth Rate -22.5% *Last Qtr.
Average % Move 1-Wk after EPS +0.0% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. % Since Details
2/11/14 Q413 -$0.13N/A N/A $6.9M$8.9M N/A -27.5% Details
10/23/13 Q313 -$0.11-$0.11 $0.00$5.7M$5.52M = +34.1% Details
7/24/13 Q213 -$0.10-$0.13 +$0.03$6.93M$4.77M = +53.9% Details
5/8/13 Q113 -$0.13-$0.16 +$0.03$4.62M$3.79M = +80.3% Details
2/6/13 Q412 -$0.07-$0.12 +$0.05$8.9M$5.95M = +51% Details
10/24/12 Q312 -$0.11-$0.14 +$0.03$4.9M$3.8M = +149.8% Details
7/25/12 Q212 -$0.11-$0.14 +$0.03$4.6M$3.65M = +186.7% Details
5/2/12 Q112 -$0.14-$0.16 +$0.02$3.2M$3.38M = +218.2% Details